MEDIA RESOURCES

MECHANISM OF ACTION IMAGES

Cretostimogene
grenadenorepvec an
oncolytic immunotherapy
(OIT)

NMIBC tumor cross section of the bladder Ta, T1, and CIS

Cretostimogene
grenadenorepvec
instillation in the bladder

Cretostimogene ,
grenadenorepvec
attaching to a CAR
receptor

E2F promoter is
permanently activated in
cancer cells: cancer cells and
healthy cells

Cretostimogene grenadenorepvec
and a CIS tumor

Cretostimogene grenadenorepvec
progeny

Cretostimogene
grenadenorepvec an
oncolytic immunotherapy
(OIT)

NMIBC CIS tumor in the
bladder

Additional
cretostimogene
grenadenorepvec
progeny being released

Follow CG Oncology on LinkedIn.